ON DEMAND: Yale Epilepsy Virtual CME Series: A Monthly Live Case-Based Webinar

Tuesday, October 5, 2021, 1:48 PM - Friday, April 11, 2025, 2:48 PM

Epilepsy and seizures affect almost 3 million Americans of all ages. Tremendous advances have been made in epilepsy treatment over the years, including new pharmacological approaches, surgery, neurostimulation, dietary modification and other nonpharmacological treatments. Despite these advances, a large proportion of patients continue to have seizures, possibly partially due to the gap between established therapies and recommended treatments and the actual care patients receive. This series will provide participants with the tools to stay up to date on new advances in the treatment of epilepsy and related disorders, and will increase participants’ awareness of emerging diagnostic and therapeutic options.

1. Apply new knowledge of emerging pharmacological treatments for epilepsy
2. Manage epilepsy in women who are pregnant or considering pregnancy
3. Discuss the role of the neurologist in the treatment of psychogenic nonepileptic attacks
4. Discuss the surgical treatment options for patients with epilepsy, including neurostimulation, laser ablation and resection
5. Discuss options for seizure safety, including rescue therapy, wearable devices and alarms
6. Demonstrate understanding of neuroimaging in epilepsy, including new approaches

Complimentary

The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The Yale School of Medicine designates this enduring material for a maximum of 7.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy
It is the policy of Yale School of Medicine, Continuing Medical Education (CME), to ensure balance, independence, objectivity, and scientific rigor in all its educational programs.  All individuals involved in the development and presentation of Accredited Continuing Education activities are required to disclose all financial relationship(s) with ineligible companies that has occurred within the past 24 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. This information is disclosed to all activity participants prior to the commencement of the educational activity.

AMA PRA Category 1 Credits™ (7.00 hours), Non-Physician Attendance (7.00 hours)

Mitigation of Relevant Financial Relationships

Yale Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

The Yale School of Medicine, Department of Neurology and Comprehensive Epilepsy Center are grateful to their supporters.